Ezetimibe vs Statins: LDL Drop, Side Effects and Which Saves You More

Ezetimibe lowers LDL cholesterol by blocking absorption in your small intestine, while statins cut LDL by slowing cholesterol production in the liver. On average, the standard 10 mg ezetimibe tablet drops LDL about 18 percent on its own, compared with 30 to 55 percent for moderate- to high-intensity statin doses. Adding ezetimibe to a statin can push LDL 13 to 25 percent lower than the statin alone. Patients who cannot reach targets or who develop muscle pain on higher statin doses often benefit from the combo.

• Adding ezetimibe to 40 mg simvastatin reduced cardiovascular events by 6.4 percent over seven years in the IMPROVE-IT outcome trial.(nejm.org)
• Muscle pain occurs in roughly 9 percent of patients on very-high-dose statins versus 4–5 percent on placebo; ezetimibe alone is not linked to higher muscle-symptom rates than placebo.(pmc.ncbi.nlm.nih.gov)
• Generic ezetimibe averages about $8 for a month’s supply, while generic atorvastatin 40 mg costs around $10; the ezetimibe-simvastatin combo pill runs closer to $38.(drugs.com)
• Ask your doctor about combination therapy if your LDL stays above 70 mg/dL after three months on the maximally tolerated statin dose.

What Ezetimibe and Statins Are

Ezetimibe is a cholesterol-absorption inhibitor approved by the FDA in 2002 that blocks the Niemann–Pick C1-like 1 (NPC1L1) transporter in the intestinal brush border, preventing dietary and biliary cholesterol from entering the bloodstream. Statins are HMG-CoA-reductase inhibitors first introduced in 1987 that curb the liver’s own cholesterol production. Both lower LDL (“bad”) cholesterol but by very different pathways, which is why clinicians often use them together.

The only dose of ezetimibe is 10 mg once daily with or without food. Statins come in multiple potencies, from 10 mg atorvastatin (moderate intensity) up to 40 mg rosuvastatin (high intensity). If you are unsure when to take yours, see our guide on the best time to take a statin.

How Each Medicine Lowers LDL Cholesterol

Ezetimibe and statins act on opposite ends of the cholesterol-supply chain.

Blocking absorption: Ezetimibe sits on intestinal NPC1L1 transporters, cutting cholesterol influx to the liver. The liver then pulls LDL particles out of the blood to make up the shortfall, lowering serum LDL by about one-fifth.(pmc.ncbi.nlm.nih.gov)

Blocking production: Statins inhibit HMG-CoA reductase inside hepatocytes. Less internal cholesterol means the liver up-regulates LDL receptors and vacuums LDL out of circulation, producing the larger 30–55 percent reductions seen with moderate- to high-intensity doses.(pubmed.ncbi.nlm.nih.gov)

Why combine them? Statin therapy can increase intestinal cholesterol absorption over time. Adding ezetimibe turns off that compensatory pathway, giving an extra 13–25 percent LDL drop without raising the statin dose.(pmc.ncbi.nlm.nih.gov)

How Much LDL Can Each Drug Drop?

Doctors choose intensity based on how far you must push LDL down. The table below shows average percentage reductions documented in well-controlled studies.

Do Outcomes Improve When You Combine Them?

The IMPROVE-IT trial gave the first hard-endpoint proof that adding ezetimibe to a statin matters clinically, not just on lab numbers.

Key findings:

• Study design: 18,144 patients hospitalized for a recent acute coronary syndrome were randomized to simvastatin 40 mg plus ezetimibe 10 mg or simvastatin alone and followed for a median 6.0 years.(nejm.org)
• Event reduction: The combination cut the primary composite of cardiovascular death, MI, unstable angina, revascularization or stroke by an absolute 2.0 percent (hazard ratio 0.936; P = 0.016).
• LDL achieved: Median on-treatment LDL was 53 mg/dL in the combo group versus 70 mg/dL with simvastatin alone.

Clinical takeaway: Every extra 10 mg/dL LDL drop translated into a ~6 percent relative risk reduction, mirroring the cholesterol-treatment trialists’ rule of thumb. Patients unable to tolerate higher statin doses can get similar outcome benefits by keeping the statin moderate and layering ezetimibe.

Side-Effect Profile: Muscle and Liver Safety

Most side effects are mild and dose-related. Understanding the odds helps you and your prescriber balance risk against benefit.

Muscle symptoms

Real incidence: In the PRIMO trial, 9.4 percent of people on 80 mg atorvastatin experienced myalgia versus 4.6 percent on placebo.(pmc.ncbi.nlm.nih.gov) Newer n-of-1 StatinWISE studies found no significant difference at moderate doses, suggesting many aches are coincidental.(pmc.ncbi.nlm.nih.gov) Ezetimibe alone has no excess muscle-pain signal over placebo.(ncbi.nlm.nih.gov)

Dose-adjustment strategy: Lower the statin to a tolerable intensity, check creatine kinase if pain persists, then add ezetimibe rather than stopping cholesterol therapy altogether. See our statin muscle pain guide for complete troubleshooting.

Liver enzyme elevations

ALT or AST above three times the upper limit of normal occur in 0.5–3 percent of statin users, most often within the first three months.(pmc.ncbi.nlm.nih.gov) In ezetimibe monotherapy studies the rate is 0.5 percent, identical to placebo, but rises to 1.3 percent when ezetimibe starts the same day as a statin.(dailymed.nlm.nih.gov) Routine baseline labs and symptom-triggered follow-up are usually sufficient.

Cost Comparison and Saving Tips

Most cholesterol medicines are now inexpensive generics, but prices still vary wildly between pharmacies. The National Average Drug Acquisition Cost (NADAC) and retail cash data from Drugs.com paint a clear picture for July 2026.

Smart savings moves:

Compare pharmacies: Enter your zip code in the Rx.com price tool before you fill so you know which local chains beat $4 programs. Use a larger statin bottle: 90-day fills of atorvastatin or rosuvastatin often cost the same as 30 days. Consider splitting: Cutting a higher-strength tablet in half can halve your cost (ask your pharmacist first). Shop combo pills carefully: The convenience of ezetimibe-simvastatin adds $20–$30 a month; two separate bottles are usually cheaper.

Who Should Consider Adding or Switching

Add ezetimibe if you need more than a moderate-intensity statin can safely deliver. Guidelines list specific groups who benefit:

• Clinical atherosclerotic cardiovascular disease (ASCVD) with LDL ≥70 mg/dL on maximally tolerated statin
• Familial hypercholesterolemia not at LDL goal
• Statin intolerance that limits intensity to below goal
• Diabetes with high ASCVD risk and residual LDL elevation

Switch to ezetimibe monotherapy only if true statin intolerance is documented and LDL targets are modest. Otherwise, newer agents such as PCSK9 inhibitors (see our Repatha guide) may be required.